Wednesday, 31st May 2023
<To guardian.ng
Search

A medical breakthrough! Promising new drug trial could help fight Alzheimer’s

By France24
07 May 2023   |   8:09 am
The Food and Drug Administration (FDA) recently granted accelerated approval to a new Alzheimer's treatment called lecanemab, which has been shown to moderately slow cognitive and functional decline in early-stage cases of the disease.

Related

18 Jan 2017
Researchers believe they may be close to perfecting a method of encouraging teeth to repair themselves, as Stuart McDill reports, making the filling a thing of the past.
9 Aug 2017
Singer-guitarist Glen Campbell, the "Rhinestone Cowboy" who went on a farewell tour to play hits such as "Wichita Lineman" and "Gentle on My Mind" before Alzheimer's disease robbed him of his talents, has died at the age of 81.
5 Jun 2021
The drug aducanumab could be approved in the US and EU soon. It effectively combats the amyloid beta plaques in the brain that are indicative of Alzheimer's disease. But does it also slow down memory loss?
4 Sep 2022
Estimated to account for up to 70 percent of dementia cases, Alzheimer's is a severe neurodegenerative disease.
21 Sep 2022
Ahead of World Alzheimer's Day, the German government's statistics office released figures showing that hospitalizations and deaths had more than doubled in the past two decades as the country ages.
21 Nov 2022
Women are nearly twice as likely as men to develop Alzheimer's disease, according to the Centers for Disease Control and Prevention (CDC) , but there is little understanding of why exactly this is. The condition is the most common form of dementia, and it affected 5.8 million North Americans in 2020.
14 Jan
Preliminary data from a September trial showed the drug slowed cognitive decline by 27% in patients. It also indicated that the treatment risks brain swelling and bleeding among some patients.
5 May
Drug developers are making progress with treatments for Alzheimer's disease, one of the leading causes of dementia.